People · Operator
Named in public records as an officer, director or promoter · active 2009–2017 · Biotechnology
| Company | Role | Sector | Stage | Raised · real | Value · est | Tied |
|---|---|---|---|---|---|---|
| Exagen Diagnostics Inc | — | Biotechnology | Series B | $88.5M | $261.4M | 2009 |
| Nanomr, Inc. | — | Biotechnology | Series A | $18.5M | $86.8M | 2010 |
| Armonica Technologies, Inc. | — | Biotechnology | Series A | $7.0M | $11.3M | 2017 |
| AgilVax, Inc. | — | Biotechnology | Seed | $4.2M | $133.2M | 2014 |
Waneta C. Tuttle at the center, the companies they're named on, and every other operator named alongside them — an interlock map of shared founding teams, boards and funds. Name-matched, so treat as a research lead.
People named alongside Waneta C. Tuttle on the same companies — an interlock signal (shared founding team, board, or fund). Name-matched, so verify before acting.
| Operator | Shared | Their companies |
|---|---|---|
| David Blivin | 2 | 14 |
| Brian Birk | 2 | 8 |
| Waneta Tuttle | 2 | 6 |
| Sally Corning | 2 | 5 |
| Victor Esch | 2 | 2 |
| Brian C Birk | 2 | 2 |
| Gavin Christensen | 1 | 23 |
| Dinesh Patel | 1 | 13 |
| Scott L. Glenn | 1 | 9 |
| Ebetuel Pallares | 1 | 7 |
| James L.L. Tullis | 1 | 6 |
| Brad Vale | 1 | 4 |
| Stuart Rose | 1 | 4 |
| Faith Charles | 1 | 4 |
| Scott Glenn | 1 | 4 |
| Lisa Davis | 1 | 3 |
| Daniel C. Burrell | 1 | 3 |
| Michael J. Walsh | 1 | 2 |
| John Bessone | 1 | 2 |
| Michael R. Walsh | 1 | 2 |
People are matched by normalized name across records; a common name may merge distinct individuals. Treat as a research lead, the same way modeled valuations are directional, not quoted.